PMC:7271924 / 29370-30017
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T532","span":{"begin":33,"end":46},"obj":"GO:0005886"},{"id":"T533","span":{"begin":113,"end":123},"obj":"GO:0035376"},{"id":"T534","span":{"begin":142,"end":161},"obj":"CL:0000623"},{"id":"T535","span":{"begin":186,"end":196},"obj":"CL:0000775"},{"id":"T536","span":{"begin":225,"end":231},"obj":"UBERON:0002405"},{"id":"T537","span":{"begin":232,"end":239},"obj":"GO:0006952"},{"id":"T538","span":{"begin":267,"end":275},"obj":"GO:0035376"},{"id":"T539","span":{"begin":280,"end":285},"obj":"NCBITaxon:10239"},{"id":"T540","span":{"begin":371,"end":379},"obj":"SP_7"},{"id":"T541","span":{"begin":400,"end":406},"obj":"GO:0007601"},{"id":"T542","span":{"begin":536,"end":540},"obj":"G_3;PG_10;PR:000003622"},{"id":"T95560","span":{"begin":33,"end":46},"obj":"GO:0005886"},{"id":"T81157","span":{"begin":113,"end":123},"obj":"GO:0035376"},{"id":"T16593","span":{"begin":142,"end":161},"obj":"CL:0000623"},{"id":"T26835","span":{"begin":186,"end":196},"obj":"CL:0000775"},{"id":"T92368","span":{"begin":225,"end":231},"obj":"UBERON:0002405"},{"id":"T25486","span":{"begin":232,"end":239},"obj":"GO:0006952"},{"id":"T28995","span":{"begin":267,"end":275},"obj":"GO:0035376"},{"id":"T87059","span":{"begin":280,"end":285},"obj":"NCBITaxon:10239"},{"id":"T26492","span":{"begin":371,"end":379},"obj":"SP_7"},{"id":"T46616","span":{"begin":400,"end":406},"obj":"GO:0007601"},{"id":"T7529","span":{"begin":536,"end":540},"obj":"G_3;PG_10;PR:000003622"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"751","span":{"begin":536,"end":540},"obj":"Gene"},{"id":"752","span":{"begin":545,"end":549},"obj":"Gene"},{"id":"753","span":{"begin":38,"end":46},"obj":"Gene"},{"id":"761","span":{"begin":309,"end":318},"obj":"Disease"},{"id":"762","span":{"begin":371,"end":379},"obj":"Disease"}],"attributes":[{"id":"A751","pred":"tao:has_database_id","subj":"751","obj":"Gene:59272"},{"id":"A752","pred":"tao:has_database_id","subj":"752","obj":"Gene:6383"},{"id":"A753","pred":"tao:has_database_id","subj":"753","obj":"Gene:43740571"},{"id":"A761","pred":"tao:has_database_id","subj":"761","obj":"MESH:D007239"},{"id":"A762","pred":"tao:has_database_id","subj":"762","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T331","span":{"begin":7,"end":12},"obj":"Body_part"},{"id":"T332","span":{"begin":33,"end":46},"obj":"Body_part"},{"id":"T333","span":{"begin":33,"end":37},"obj":"Body_part"},{"id":"T334","span":{"begin":113,"end":117},"obj":"Body_part"},{"id":"T335","span":{"begin":142,"end":161},"obj":"Body_part"},{"id":"T336","span":{"begin":157,"end":161},"obj":"Body_part"},{"id":"T337","span":{"begin":186,"end":196},"obj":"Body_part"},{"id":"T338","span":{"begin":296,"end":301},"obj":"Body_part"},{"id":"T339","span":{"begin":545,"end":549},"obj":"Body_part"}],"attributes":[{"id":"A331","pred":"fma_id","subj":"T331","obj":"http://purl.org/sig/ont/fma/fma82834"},{"id":"A332","pred":"fma_id","subj":"T332","obj":"http://purl.org/sig/ont/fma/fma63841"},{"id":"A333","pred":"fma_id","subj":"T333","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A334","pred":"fma_id","subj":"T334","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A335","pred":"fma_id","subj":"T335","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A336","pred":"fma_id","subj":"T336","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A337","pred":"fma_id","subj":"T337","obj":"http://purl.org/sig/ont/fma/fma62860"},{"id":"A338","pred":"fma_id","subj":"T338","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A339","pred":"fma_id","subj":"T339","obj":"http://purl.org/sig/ont/fma/fma82834"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T111","span":{"begin":309,"end":318},"obj":"Disease"},{"id":"T112","span":{"begin":371,"end":379},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T392","span":{"begin":7,"end":12},"obj":"http://purl.obolibrary.org/obo/PR_000001307"},{"id":"T393","span":{"begin":33,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T394","span":{"begin":38,"end":46},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T395","span":{"begin":113,"end":117},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T396","span":{"begin":142,"end":161},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T397","span":{"begin":162,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T398","span":{"begin":280,"end":285},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T399","span":{"begin":296,"end":301},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T400","span":{"begin":398,"end":399},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T401","span":{"begin":514,"end":515},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T357","span":{"begin":130,"end":132},"obj":"Chemical"},{"id":"T358","span":{"begin":600,"end":602},"obj":"Chemical"}],"attributes":[{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_73585"},{"id":"A358","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_73585"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T64","span":{"begin":142,"end":170},"obj":"http://purl.obolibrary.org/obo/GO_0030101"},{"id":"T65","span":{"begin":186,"end":208},"obj":"http://purl.obolibrary.org/obo/GO_0070488"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T232","span":{"begin":130,"end":319},"obj":"Sentence"},{"id":"T233","span":{"begin":320,"end":488},"obj":"Sentence"},{"id":"T234","span":{"begin":489,"end":599},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
MyTest
{"project":"MyTest","denotations":[{"id":"32574271-21887302-34514763","span":{"begin":125,"end":127},"obj":"21887302"},{"id":"32574271-15655079-34514764","span":{"begin":241,"end":244},"obj":"15655079"},{"id":"32574271-32228252-34514765","span":{"begin":594,"end":595},"obj":"32228252"},{"id":"32574271-32334062-34514765","span":{"begin":594,"end":595},"obj":"32334062"},{"id":"32574271-32333836-34514765","span":{"begin":594,"end":595},"obj":"32333836"},{"id":"32574271-32395702-34514765","span":{"begin":594,"end":595},"obj":"32395702"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
TEST0
{"project":"TEST0","denotations":[{"id":"32574271-136-142-2882355","span":{"begin":125,"end":127},"obj":"[\"21887302\"]"},{"id":"32574271-111-118-2882356","span":{"begin":241,"end":244},"obj":"[\"15655079\"]"},{"id":"32574271-105-110-2882357","span":{"begin":594,"end":595},"obj":"[\"32228252\", \"32334062\", \"32333836\", \"32395702\"]"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}
2_test
{"project":"2_test","denotations":[{"id":"32574271-21887302-34514763","span":{"begin":125,"end":127},"obj":"21887302"},{"id":"32574271-15655079-34514764","span":{"begin":241,"end":244},"obj":"15655079"},{"id":"32574271-32228252-34514765","span":{"begin":594,"end":595},"obj":"32228252"},{"id":"32574271-32334062-34514765","span":{"begin":594,"end":595},"obj":"32334062"},{"id":"32574271-32333836-34514765","span":{"begin":594,"end":595},"obj":"32333836"},{"id":"32574271-32395702-34514765","span":{"begin":594,"end":595},"obj":"32395702"}],"text":"und to HSPGs then rolls onto the cell membrane and scans for specific entry receptors, which leads to subsequent cell entry (99). LF enhances natural killer cell activity and stimulates neutrophil aggregation and adhesion in immune defense (135) and can restrict the entry of the virus into host cells during infection. We suggest that this process might be the same for COVID-19 (see Figure 6 for a visual representation), thereby offering useful strategies for prevention and treatment. Currently, there is also a renewed interest in ACE2 and HSPG blocking, as discussed in the introduction (5–8). LF may therefore be an excellent supplement to "}